China’s desire for endless youth is wiping out donkeys – can scientists help?

This development highlights a fascinating intersection of traditional medicine, biotechnology, and ethical consumption within Asia's economic landscape. The insatiable demand for ejiao, driven by China's growing middle class, underscores the significant market power of traditional health and beauty products, even when their efficacy is debated by Western science. This creates a unique opportunity for biotech startups and research institutions to leverage advanced scientific methods, such as lab-grown collagen, to address supply chain issues and ethical concerns in established Asian markets.

The potential for lab-grown alternatives to traditional animal-derived products could reshape several industries across Asia, from pharmaceuticals to cosmetics. It signals a shift towards sustainable and ethical sourcing, driven by both environmental concerns and consumer preferences for purer, more controlled ingredients. For the Asian tech ecosystem, this presents a fertile ground for innovation in cellular agriculture and synthetic biology, attracting investment and fostering new ventures that can meet traditional demands with modern solutions, thereby mitigating ecological impact while capitalizing on robust market trends.